Phibro Animal Health (NASDAQ:PAHC) Given New $20.00 Price Target at Barclays

Phibro Animal Health (NASDAQ:PAHC) had its target price boosted by Barclays from $13.00 to $20.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has an underweight rating on the stock.

Several other research analysts also recently commented on PAHC. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. Bank of America lifted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $16.50.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $25.06 on Tuesday. The business’s fifty day moving average is $22.46 and its 200 day moving average is $19.52. The firm has a market cap of $1.01 billion, a price-to-earnings ratio of 58.28, a PEG ratio of 0.65 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a 52-week low of $9.40 and a 52-week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The firm had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. Research analysts predict that Phibro Animal Health will post 1.63 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.92%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

Insider Buying and Selling

In other news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction on Wednesday, September 4th. The shares were acquired at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the transaction, the director now directly owns 25,000 shares of the company’s stock, valued at approximately $500,500. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 50.07% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. CWM LLC grew its holdings in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares during the last quarter. nVerses Capital LLC purchased a new stake in Phibro Animal Health during the third quarter valued at about $70,000. China Universal Asset Management Co. Ltd. grew its stake in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after buying an additional 1,522 shares during the last quarter. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health in the second quarter worth about $83,000. Finally, Illinois Municipal Retirement Fund lifted its stake in shares of Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after acquiring an additional 765 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.